Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hack

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|March 15, 2019
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancerPeter A Fasching, Paul Gass, Lothar Häberle, et al.
Elife|June 3, 2020
Correction: Collective forces of tumor spheroids in three-dimensional biopolymer networksChristoph Mark, Thomas J Grundy, Pamela L Strissel, et al.
Archives of Gynecology and Obstetrics|November 17, 2020
Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in GermanyDonata Grimm, Petra Voiss, Daniela Paepke, et al.
Oncoimmunology|January 3, 2024
Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancerLukas Heger, Gordon F Heidkamp, Lukas Amon, et al.
Elife|May 1, 2020
Collective forces of tumor spheroids in three-dimensional biopolymer networksChristoph Mark, Thomas J Grundy, Pamela L Strissel, et al.
Anticancer Research|February 11, 2014
Health utilities in gynecological oncology and mastology in GermanyThomas Hildebrandt, Falk C Thiel, Peter A Fasching, et al.
Anticancer Research|January 2, 2016
Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with AnthracyclineKatrin Almstedt, Peter A Fasching, Anton Scharl, et al.
Complementary Medicine Research|June 17, 2020
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative MedicineCarolin C Hack, Sonja Wasner, Julia Meyer, et al.
ESMO Open|October 26, 2024
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancerK Seitz, C Goossens, H Huebner, et al.
European Journal of Immunology|March 21, 2003
Biochemical and functional characterization of the interaction between pentraxin 3 and C1qAlma J Nauta, Barbara Bottazzi, Alberto Mantovani, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|March 15, 2019
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancerPeter A Fasching, Paul Gass, Lothar Häberle, et al.
Elife|June 3, 2020
Correction: Collective forces of tumor spheroids in three-dimensional biopolymer networksChristoph Mark, Thomas J Grundy, Pamela L Strissel, et al.
Archives of Gynecology and Obstetrics|November 17, 2020
Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in GermanyDonata Grimm, Petra Voiss, Daniela Paepke, et al.
Oncoimmunology|January 3, 2024
Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancerLukas Heger, Gordon F Heidkamp, Lukas Amon, et al.
Elife|May 1, 2020
Collective forces of tumor spheroids in three-dimensional biopolymer networksChristoph Mark, Thomas J Grundy, Pamela L Strissel, et al.
Anticancer Research|February 11, 2014
Health utilities in gynecological oncology and mastology in GermanyThomas Hildebrandt, Falk C Thiel, Peter A Fasching, et al.
Anticancer Research|January 2, 2016
Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with AnthracyclineKatrin Almstedt, Peter A Fasching, Anton Scharl, et al.
Complementary Medicine Research|June 17, 2020
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative MedicineCarolin C Hack, Sonja Wasner, Julia Meyer, et al.
ESMO Open|October 26, 2024
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancerK Seitz, C Goossens, H Huebner, et al.
European Journal of Immunology|March 21, 2003
Biochemical and functional characterization of the interaction between pentraxin 3 and C1qAlma J Nauta, Barbara Bottazzi, Alberto Mantovani, et al.
Pageof 15